Uncomplicated chronic musculoskeletal rachialgia (neck, mid-back or lower back) Musculoskeletal Diseases Dorsalgia
Conditions
Interventions
True auriculotherapy using pressure with vaccaria seeds (TAP):
Application of auricular implants with vaccaria seeds (vaccaria segetalis Garcke, known in China as Wang bu liu xing) as an individualis
Sponsors
Carlos III Health Institute (Spain)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Both males and females, aged at least 18 years 2. Uncomplicated chronic muscular-skeletal rachialgia (neck, mid-back or lower back), diagnosed by clinical background and physical examination 3. Have not previously received treatment with auricular implants
Exclusion criteria
Exclusion criteria: 1. Protrusion or prolapse of one or more intervertebral discs with concurrent neurological symptoms 2. Infectious spondylopathy 3. Previous surgery of the spinal column 4. Rachialgia caused by inflammatory disease, malign or autoimmmune 5. Congenital deformities of the spinal column, except mild degrees of scoliosis or lordosis 6. Vertebral fractures 7. Spinal stenosis 8. Spondylolysis or spondylolystesis 9. Skin complaints in the auricular pavilion or allergy to sticking plaster 10. Pregnancy 11. Lawsuits brought by reason of rachialgia 12. Incapacity to fill in the questionnaires or respond to the evaluator's questions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in pain intensity, measured on the 100 mm visual analogue scale (VAS), at 9 weeks after beginning treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Changes in pain intensity, measured on the 100 mm VAS, at 6 months after beginning treatment 2. Changes in the McGill Pain Questionnaire (MPQ), at the end of treatment and after 6 months 3. Satisfaction on the improvement perceived by the patient, measured at 9 weeks 4. Changes in health-related quality of life, according to the Spanish version of the 12-item Short Form health survey, version 2, at the end of treatment and after 6 months 5. Changes in the results of the Lattinen test and in the consumption of analgesics and NSAIDs (whether or not prescribed by the GP), at the time of randomisation, after each treatment session, at the end of treatment and after 6 months | — |
Countries
Spain
Outcome results
None listed